20160419 AACR Poster PR Final
Category: Press release
Transgene Hires Two Senior Pharmaceutical Industry Executives to Join Leadership Team
20160317 Appointments PR Final
Transgene Reports 2015 Financial Results and Provides Outlook for 2016 (webcast)
20160309 FY 2015 results version FINALE
Transgene Announces Participation at Upcoming Investor Events
20160302 March April 2016 IR events ENG
Transgene and ABL Announce the Acquisition by ABL Europe of Transgene’s Production Asset
20160203 PR ABL TG SYMPHONY
EIB lends EUR 20m to Transgene
20160128 PR transgene BEI final version
Transgene Announces Financial Calendar for 2016
20160108 financial calendar_EN ver 1
Transgene enters new phase in its strategic development
20160107 Strategic update ENG clean
Transgene Announces First Patient Randomized in Multinational Phase 3 Trial for Pexa-Vec Oncolytic Immunotherapy in Advanced Liver Cancer
20160106 Ph 3 pexa vec in HCC trial initiation VER8
Transgene Announces Publication in “The Lancet Oncology” of Phase 2b TIME Trial Results with TG4010 Immunotherapy in Non-Small Cell Lung Cancer
20151223_TIME Ph2b Lancet Oncology 2015_PR EN